Telix Joins Forces with University Hospital Essen on PROMISE-PET: Optimizing Patient Management through AI-enabled PSMA-PET Imaging

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

• Telix's AI platform has the potential to build on existing results and leverage one of the world's largest PSMA-PET datasets to support improved risk stratification and inform future guideline recommendations and clinical decision making

  80% confidence

• Working with leading investigators and having access to global, longitudinal, standardized PSMA-PET data will enable Telix to build, test and validate clinically relevant prognostic models that will help clinicians in treatment and management of patients with prostate cancer

  80% confidence

• PSMA-PET imaging represents a significant advance in prostate cancer management and is now considered standard of care, offering greater accuracy than conventional imaging

  80% confidence

Cited in these Via News reports

• Google's Medical AI Safety Concerns Mount as LLMs Deploy to Military Targeting Worldwide →
• Humanoid Robots Enter Commercial Markets as Boston Dynamics Completes Testing Phase →
• NVIDIA Robotics Platform Gains Traction in Global Manufacturing Through ABB, Universal Robots Deals →
• Open-Source AI Models Gain Ground Against Big Tech in Global Development Race →
• Open-Source AI Models Match Big Tech Performance as Global Sovereignty Concerns Reshape Industry →
• Pentagon Bans Claude AI as Military Competition Triggers Global Sovereignty Race →
• Pentagon Bans Claude AI as US, India, China Build Rival Tech Ecosystems →
• Tech Giants Add AI Safety Warnings as Military, Medical Applications Draw Global Scrutiny →